János Szlávik
- Infectious Diseases top 10%
- Immunology
- Epidemiology
- Virology top 10%
- Molecular Biology
- Co-authors
- Eszter ÚjhelyiDénes BánhegyiIstván Vályi‐NagyBotond LakatosZoltán ProhászkaGeorge FüstSteffen ThielNyasha Bakare
- Topics
- COVID-19 Clinical Research Studies (15 papers)SARS-CoV-2 and COVID-19 Research (10 papers)Long-Term Effects of COVID-19 (10 papers)
- Cited by
- VirologyInfectious DiseasesHealth
In The Last Decade
János Szlávik
33 papers receiving 322 citations
Peers
Comparison fields: 5 of 67
- Infectious Diseases 164
- Immunology 80
- Epidemiology 70
- Virology 55
- Molecular Biology 43
Countries citing papers authored by János Szlávik
This map shows the geographic impact of János Szlávik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by János Szlávik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites János Szlávik more than expected).
Fields of papers citing papers by János Szlávik
This network shows the impact of papers produced by János Szlávik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by János Szlávik. The network helps show where János Szlávik may publish in the future.
Co-authorship network of co-authors of János Szlávik
This figure shows the co-authorship network connecting the top 25 collaborators of János Szlávik. A scholar is included among the top collaborators of János Szlávik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with János Szlávik. János Szlávik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 10 | |
| 8 | 1 | |
| 9 | 14 | |
| 10 | 19 | |
| 11 | 1 | |
| 12 | 6 | |
| 13 | Citokinellenes terápia az új típusú koronavírus okozta megbetegedés (COVID–19) kezelésében – tocilizumab elsőként való alkalmazása egy hazai infektológiai osztályon (A COVID–19-pandémia orvosszakmai kérdései) | 6 |
| 14 | 8 | |
| 15 | 4 | |
| 16 | 1 | |
| 17 | 23 | |
| 18 | 51 | |
| 19 | 6 | |
| 20 | 24 |
About János Szlávik
János Szlávik is a scholar working on Virology, Infectious Diseases and Neurology, having authored 35 papers that have together received 328 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (15 papers), SARS-CoV-2 and COVID-19 Research (10 papers) and Long-Term Effects of COVID-19 (10 papers). The work is most often cited by research in Virology (55 citations), Infectious Diseases (164 citations) and Health (39 citations). János Szlávik has collaborated with scholars based in Hungary, France and Spain. Frequent co-authors include Eszter Újhelyi, Dénes Bánhegyi, István Vályi‐Nagy, Botond Lakatos, Zoltán Prohászka, George Füst, Steffen Thiel, Nyasha Bakare, Sandra A. Calarota and Ilona Bobek. Their work appears in journals such as PLoS ONE, Journal of Hepatology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.